Atrium Therapeutics: H.C. Wainwright cuts target price to $20 from $25
RNA•H.C. Wainwright cut its target price for Atrium Therapeutics to $20 from $25.
Related News
Seaport Therapeutics to present at Stifel Healthcare Conference
SPTX•
Landstar System: Stifel cuts target price to $179 from $197
LSTR•
American Tower: Bernstein raises target price to $221 from $212
AMT•
IQVIA Holdings target price raised to $346 from $329 by Truist Securities
IQV•
Specialized equipment maker Terex Q3 sales beat on higher shipment volumes
TEX•